expert roundtables

Treatment Goals and Strategies for Patients With Primary Progressive Multiple Sclerosis
Neurology

Treatment Goals and Strategies for Patients With Primary Progressive Multiple Sclerosis

expert roundtables
By Aaron Miller, MD; Patricia K. Coyle, MD, FAAN, FANA; Scott Newsome, DO, MSCS, FAAN
Novel Therapeutic Combinations for Chronic Lymphocytic Leukemia
Oncology

Novel Therapeutic Combinations for Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Discussing Safety and Tolerability of Disease-Modifying Antirheumatic Drugs With Patients
Rheumatology

Discussing Safety and Tolerability of Disease-Modifying Antirheumatic Drugs With Patients

expert roundtables
By John R. P. Tesser, MD; Jonathan Kay, MD; Leonard H. Calabrese, DO; Vibeke Strand, MD, MACR, FACP
Role of Age and Fitness in Selecting Treatment for Chronic Lymphocytic Leukemia
Oncology

Role of Age and Fitness in Selecting Treatment for Chronic Lymphocytic Leukemia

expert roundtables
By Anthony R. Mato, MD, MSCE; Jan A. Burger, MD, PhD; Jennifer R. Brown, MD, PhD
Clinical Impact of Non–Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis
Rheumatology

Clinical Impact of Non–Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis

expert roundtables
By John R. P. Tesser, MD; Jonathan Kay, MD; Leonard H. Calabrese, DO; Vibeke Strand, MD, MACR, FACP
Load More